Jasmeen Dara
About
Jasmeen Dara is a scholar working on Hematology, Immunology and Infectious Diseases.
According to data from OpenAlex, Jasmeen Dara has authored 23 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 11 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Jasmeen Dara's work include Hematopoietic Stem Cell Transplantation (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Acute Myeloid Leukemia Research (3 papers). Jasmeen Dara is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Acute Myeloid Leukemia Research (3 papers). Jasmeen Dara collaborates with scholars based in United States, United Kingdom and Austria. Jasmeen Dara's co-authors include Christopher C. Dvorak, Alexis Melton, Kristin A. Shimano, James N. Huang, Sandhya Kharbanda, Morton J. Cowan, Christine S. Higham, Morna J. Dorsey, Lena E. Winestone and Jennifer M. Puck and has published in prestigious journals such as Blood, Journal of Allergy and Clinical Immunology and The Pediatric Infectious Disease Journal.
In The Last Decade
Jasmeen Dara
21 papers receiving 165 citations
Peers
Jasmeen Dara
Nicholas M. Murphy Australia
Michelle Kuxhausen United States
Kristin Knust United States
Anjulika Chawla United States
Pasqualina De Leo Italy
Jessica J. Lee United States
Luka Verrest Netherlands
Abigail Severn United Kingdom
Jihène Bouguila Tunisia
Soonie R Patel United Kingdom
Citations per year, relative to Jasmeen Dara Jasmeen Dara (= 1×)
peers
Nicholas M. Murphy
Countries citing papers authored by Jasmeen Dara
Since
Specialization
Citations
This map shows the geographic impact of Jasmeen Dara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmeen Dara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmeen Dara more than expected).
Fields of papers citing papers by Jasmeen Dara
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jasmeen Dara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmeen Dara. The network helps show where Jasmeen Dara may publish in the future.
Co-authorship network of co-authors of Jasmeen Dara
This figure shows the co-authorship network connecting the top 25 collaborators of Jasmeen Dara. A scholar is included among the top collaborators of Jasmeen Dara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmeen Dara. Jasmeen Dara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Marón, Gabriela, Michael Boeckh, Genovefa A. Papanicolaou, et al.. (2025). P-103. Adenoviremia Clearance Following Treatment with Intravenous (IV) Brincidofovir (BCV) in Immunocompromised Patients is Associated with Positive Clinical Disease Response: Preliminary Outcomes from the ATHENA Phase IIa Study. Open Forum Infectious Diseases. 12(Supplement_1).
2.
Higham, Christine S., Kristin A. Shimano, Sandhya Kharbanda, et al.. (2024). Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy. Transplantation and Cellular Therapy. 30(9). 931.e1–931.e10.
3.
Dvorak, Christopher C., Janel Long‐Boyle, Sandhya Kharbanda, et al.. (2024). Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric Protocols. Transplantation and Cellular Therapy. 30(7). 690.e1–690.e16.
4.
Grimley, Michael, Gabriela Marón, Carlos A. Gómez, et al.. (2024). Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection. Transplantation and Cellular Therapy. 30(2). S89–S89.
5.
Grimley, Michael, Gabriela Marón, Carlos A. Gómez, et al.. (2023). Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection. Blood. 142(Supplement 1). 112–112.
6.
Higham, Christine S., Kristin A. Shimano, Alexis Melton, et al.. (2022). A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high‐risk pediatric patients. Pediatric Blood & Cancer. 69(5). e29641–e29641.
7.
Chan, Alice, Jasmeen Dara, Christopher C. Dvorak, et al.. (2022). Impact of Genetic Diagnosis on the Outcome of Hematopoietic Stem Cell Transplant in Primary Immunodeficiency Disorders. Journal of Clinical Immunology. 43(3). 636–646.
8.
Higham, Christine S., Kristin A. Shimano, Alexis Melton, et al.. (2021). Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis. Blood Advances. 5(8). 2106–2114.
9.
Higham, Christine S., Alexis Melton, Sandhya Kharbanda, et al.. (2020). A Pilot Trial of Pre-Transplant Risk Stratification and Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-Risk Pediatric Hematopoietic Stem Cell Transplant Patients. Blood. 136(Supplement 1). 9–10.
10.
Contreras, Cristina F., Janel Long-Boyle, Kristin A. Shimano, et al.. (2020). Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell Transplants. Biology of Blood and Marrow Transplantation. 26(9). 1646–1654.
11.
Dara, Jasmeen, et al.. (2020). Unknown cytomegalovirus serostatus in primary immunodeficiency disorders: A new category of transplant recipients. Transplant Infectious Disease. 23(2). e13504–e13504.
12.
Cowan, Morton J., Jason Yu, Carol Fraser‐Browne, et al.. (2020). Early Outcome of a Phase I/II Clinical Trial (NCT03538899) of Gene-Corrected Autologous CD34+ Hematopoietic Cells and Low-Exposure Busulfan in Newly Diagnosed Patients with Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID). Biology of Blood and Marrow Transplantation. 26(3). S88–S89.
13.
Dvorak, Christopher C., Janel Long‐Boyle, Jasmeen Dara, et al.. (2019). Low Exposure Busulfan Conditioning to Achieve Sufficient Multilineage Chimerism in Patients with Severe Combined Immunodeficiency. Biology of Blood and Marrow Transplantation. 25(7). 1355–1362.
14.
Hermiston, Michelle L., Kristin A. Shimano, Sandhya Kharbanda, et al.. (2019). Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis. Blood. 134(Supplement_1). 3343–3343.
15.
Friend, Brian D., Christine S. Higham, Jasmeen Dara, et al.. (2019). The Impact of Total Body Irradiation-Based Regimens on Outcomes in Children and Young Adults with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(3). S197–S198.
16.
Contreras, Cristina F., Janel Long-Boyle, Kristin A. Shimano, et al.. (2019). Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants. Blood. 134(Supplement_1). 4481–4481.
17.
Dara, Jasmeen, et al.. (2018). Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report. PubMed. 5(1). 22–22.
18.
Gialanella, Philip, et al.. (2017). Fulminant Sepsis Due to Granulibacter bethesdensis in a 4-Year-Old Boy With X-Linked Chronic Granulomatous Disease. The Pediatric Infectious Disease Journal. 36(12). 1165–1166.
19.
Dara, Jasmeen, Anna Dow, Elizabeth A. Cromwell, et al.. (2015). Multivariable analysis to determine if HIV-1 Tat dicysteine motif is associated with neurodevelopmental delay in HIV-infected children in Malawi. Behavioral and Brain Functions. 11(1). 38–38.
20.
Dara, Jasmeen, Liang Chen, Michael H. Levi, Barry N. Kreiswirth, & Rebecca Pellett Madan. (2013). Microbiological and Genetic Characterization of Carbapenem-Resistant Klebsiella pneumoniae Isolated From Pediatric Patients. Journal of the Pediatric Infectious Diseases Society. 3(1). e10–e14.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Nicholas M. Murphy Breakdown of academic impact, for papers by Michelle Kuxhausen Breakdown of academic impact, for papers by Kristin Knust Breakdown of academic impact, for papers by Anjulika Chawla Breakdown of academic impact, for papers by Pasqualina De Leo Breakdown of academic impact, for papers by Jessica J. Lee Breakdown of academic impact, for papers by Luka Verrest Breakdown of academic impact, for papers by Abigail Severn Breakdown of academic impact, for papers by Jihène Bouguila Breakdown of academic impact, for papers by Soonie R Patel